Overview
HIV-related lung cancer is a term that was previously used to describe lung cancer occurring in people living with HIV (human immunodeficiency virus). This condition is now considered 'obsolete' as a separate disease category in medical classification systems, meaning it is no longer listed as a distinct rare disease. Instead, lung cancer in people with HIV is generally managed as lung cancer with an underlying immune condition, rather than as a unique separate disease. People living with HIV have a higher risk of developing lung cancer compared to the general population. This increased risk is thought to be due to a combination of factors, including a weakened immune system, higher rates of smoking among people with HIV, chronic inflammation, and the effects of the virus itself on lung tissue. The most common type of lung cancer seen in this group is non-small cell lung cancer. Symptoms of lung cancer in people with HIV are similar to those in the general population and may include a persistent cough, coughing up blood, chest pain, shortness of breath, unexplained weight loss, and fatigue. Treatment typically involves a combination of antiretroviral therapy to manage HIV alongside standard cancer treatments such as surgery, chemotherapy, radiation, immunotherapy, or targeted therapy, depending on the type and stage of cancer.
Key symptoms:
Persistent or worsening coughCoughing up blood or blood-tinged mucusChest pain or tightnessShortness of breathUnexplained weight lossExtreme tiredness or fatigueLoss of appetiteHoarse voiceFrequent lung infections such as pneumoniaSwollen lymph nodes in the neck or chestBone pain if cancer has spread
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: HIV-related lung cancer.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: HIV-related lung cancer at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: HIV-related lung cancer.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: HIV-related lung cancer.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: HIV-related lung cancer.
Start the conversation →Latest news about OBSOLETE: HIV-related lung cancer
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What type and stage of lung cancer do I have, and what does that mean for my treatment options?,How will my HIV medications interact with my cancer treatment, and will my antiretroviral therapy need to change?,Am I eligible for targeted therapy or immunotherapy based on my tumor's genetic profile?,How will my immune system (CD4 count) affect my ability to tolerate cancer treatment?,Should I be enrolled in any clinical trials specifically for people with HIV and lung cancer?,What support services are available to help me manage both HIV and cancer at the same time?,What symptoms should prompt me to seek emergency care during treatment?
Common questions about OBSOLETE: HIV-related lung cancer
What is OBSOLETE: HIV-related lung cancer?
HIV-related lung cancer is a term that was previously used to describe lung cancer occurring in people living with HIV (human immunodeficiency virus). This condition is now considered 'obsolete' as a separate disease category in medical classification systems, meaning it is no longer listed as a distinct rare disease. Instead, lung cancer in people with HIV is generally managed as lung cancer with an underlying immune condition, rather than as a unique separate disease. People living with HIV have a higher risk of developing lung cancer compared to the general population. This increased risk
At what age does OBSOLETE: HIV-related lung cancer typically begin?
Typical onset of OBSOLETE: HIV-related lung cancer is adult. Age of onset can vary across affected individuals.